• 1 イントロダクション

  • 1.1 調査の前提条件と市場の定義

  • 1.2 本調査の範囲

• 2 調査手法

• 3 エグゼクティブサマリー

• 4 市場ダイナミクス

  • 4.1 市場の促進要因

  • 4.2 市場の抑制要因

  • 4.3 業界魅力度 - ポーターのファイブフォース分析

    • 4.3.1 新規参入の脅威

    • 4.3.2 買い手・消費者の交渉力

    • 4.3.3 サプライヤーの交渉力

    • 4.3.4 代替品の脅威

    • 4.3.5 競合・競争状況の激しさ

• 5 市場セグメンテーション

  • 5.1 ソース

    • 5.1.1 植物性イノシトール

    • 5.1.2 シンセティックイノシトール

  • 5.2 アプリケーション

    • 5.2.1 栄養補助サプリメント

    • 5.2.2 飲料

    • 5.2.3 飼料産業

    • 5.2.4 医薬品業界

    • 5.2.5 その他の用途

  • 5.3 地域別

    • 5.3.1 北米

      • 5.3.1.1 米国
      • 5.3.1.2 カナダ
      • 5.3.1.3 メキシコ
      • 5.3.1.4 その他の北米

    • 5.3.2 ヨーロッパ

      • 5.3.2.1 英国
      • 5.3.2.2 ドイツ
      • 5.3.2.3 フランス
      • 5.3.2.4 ロシア
      • 5.3.2.5 イタリア
      • 5.3.2.6 スペイン
      • 5.3.2.7 その他のヨーロッパ

    • 5.3.3 アジア太平洋

      • 5.3.3.1 インド
      • 5.3.3.2 中国
      • 5.3.3.3 日本
      • 5.3.3.4 オーストラリア
      • 5.3.3.5 その他のアジア太平洋

    • 5.3.4 南米

      • 5.3.4.1 ブラジル
      • 5.3.4.2 アルゼンチン
      • 5.3.4.3 その他の南米

    • 5.3.5 中東・アフリカ

      • 5.3.5.1 南アフリカ
      • 5.3.5.2 サウジアラビア
      • 5.3.5.3 その他の中東・アフリカ

• 6 競合情勢

  • 6.1 有力な戦略

  • 6.2 市場シェア分析

  • 6.3 企業プロファイル

    • 6.3.1 Koninklijke DSM NV

    • 6.3.2 Zhucheng Haotian Pharm Co. Ltd

    • 6.3.3 T.J. Clark & Company

    • 6.3.4 Hebei Yuwei Biotechnology Co. Ltd

    • 6.3.5 Jingkai Biotechnology

    • 6.3.6 Shandong Runde Biotechnology Co

    • 6.3.7 Mr. Bill's Pipe & Tobacco Company

    • 6.3.8 Charles Bowman & Company

    • 6.3.9 Asiamerica Group Inc

    • 6.3.10 Ronas Chemicals Ind. Co. Ltd

• 7 市場機会と今後の動向

The Inositol Market size is estimated at USD 146.25 million in 2024, and is expected to reach USD 206.86 million by 2029, growing at a CAGR of 7.18% during the forecast period (2024-2029).

Inositol is a naturally occurring nutrient that is usually classified as a carbocyclic polyol. The most common form is sometimes referred to as myo-inositol. In the human body, it plays a major role in preventing the collection of fats in the liver, as well as promoting healthy hair growth. A growing number of people are affected by diseases like PCOS, and diabetes. and others, due to the adoption of a poor lifestyle and increased consumption of junk food, is leading to a rise in the demand for drugs and supplements containing inositol, owing to its many curing properties as it is a member of the vitamin B complex. For instance, according to the International Diabetes Federation western pacific region had the most diabetic patients in 2021, that were around 206 million.

It is expected that greater initiatives toward creating awareness about the health benefits of inositol among consumers and exploring new and innovative applications of the ingredient in food, beverages, and drug products, can propel the growth of the market in the future. Inositol may take various forms, however, the most commonly found form is Myo-inositol. In addition, inositol is commonly used for enhancing bacterial and yeast growth and is commonly used as an additive for food. Furthermore, dietary supplements can also be manufactured using it, either as powders or capsules. Among the various applications of inositol, the versatility of its use is one of the most improbable facets that has fueled its growth over the years.

Inositol Market Trends

Increasing Demand for Inositol in Pharmaceutical Industry

Increasing demand for products with inositol content among women suffering from polycystic ovarian syndrome worldwide is a major factor expected to drive the growth of the inositol market. The prevalence of diseases like PCOS in women has also led to extensive use of inositol in the manufacture of medicines to cure PCOS, as it aids in increasing progesterone, lowering testosterone levels, decreasing luteinizing hormones, diabetes, and inducing weight loss. Increasing demand from the pharmaceutical sector for medicine preparation that aids in the treatment of neonatal respiratory distress syndrome in infants and diabetes is another factor expected to drive the market during the forecast period.

The demand for inositol is also rising, as it helps cure hair fall, depression, and other health problems the current generation faces due to the prominence of unhealthy eating habits and lifestyles. Such benefits may increase the demand for supplements and propel the market. According to the new rules, dietary supplements produced or sold in the European Union (EU) can contain only EC-approved components. Since myoinositol supplements are now considered safe for human ingestion, this rule should increase their demand. Manufacturers' and researchers' approach toward increasing the use of inositol in cancer medicine preparation is another factor expected to further support the growth of the market during the forecast period.

North America Dominates the Market

North America is expected to continue registering significant demand for inositol during the forecast period. The high prevalence of polycystic ovary syndrome, digestive disorders, and lifestyle-related diseases due to poor eating habits and high consumption of processed food is expected to drive the demand for inositol supplements. The market in the region is expected to witness significant growth, owing to the growing pharmaceutical sector and increasing government spending on the healthcare sector. Inositol is used to improve the growth of microbes, and yeast frequently uses additives found in food. It can be used to create nutritional supplements, either in the form of powder or cases. One factor that has driven the market's growth over the long haul is the diversity in how inositol is used. The growing number of people with deficiencies encouraged the development of inositols. As the market for healthy food items rises, and with significant players located in the region, North America is well-positioned to become the market leader. The presence of regional players operating in the countries offering innovative products is expected to boost the growth of the market.

Inositol Industry Overview

The inositol market is highly competitive in nature, with the presence of global players such as Koninklijke DSM NV, Shandong Runde Biotechnology Co., Charles Bowman & Company, Zhucheng Haotian Pharm Co. Ltd, and Asiamerica Group Inc. The key players are adopting strategic approaches such as product launches, partnerships, and expansion to strengthen their position in the market. In February 2021, BASF SE introduced its newest Myo-Inositol supplements under the Inositol brand. The company established a novel method of producing this product, which is more efficient than the prior method and uses renewable raw materials.

The companies are investing in R&D activities to boost the demand for supplements amid the surging awareness about health issues. The government is also taking the initiative to ensure the safety and quality of the products. The companies are following rules and regulations issued by governments to attract customers.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

• 1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition

  • 1.2 Scope of the Study

• 2 RESEARCH METHODOLOGY

• 3 EXECUTIVE SUMMARY

• 4 MARKET DYNAMICS

  • 4.1 Market Drivers

  • 4.2 Market Restraints

  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis

    • 4.3.1 Threat of New Entrants

    • 4.3.2 Bargaining Power of Buyers/Consumers

    • 4.3.3 Bargaining Power of Suppliers

    • 4.3.4 Threat of Substitute Products

    • 4.3.5 Intensity of Competitive Rivalry

• 5 MARKET SEGMENTATION

  • 5.1 Source

    • 5.1.1 Plant-based Inositol

    • 5.1.2 Synthetic Inositol

  • 5.2 Application

    • 5.2.1 Dietary Supplement

    • 5.2.2 Beverage

    • 5.2.3 Feed Industry

    • 5.2.4 Pharmaceutical Industry

    • 5.2.5 Other Applications

  • 5.3 Geography

    • 5.3.1 North America

      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
      • 5.3.1.4 Rest of North America

    • 5.3.2 Europe

      • 5.3.2.1 United Kingdom
      • 5.3.2.2 Germany
      • 5.3.2.3 France
      • 5.3.2.4 Russia
      • 5.3.2.5 Italy
      • 5.3.2.6 Spain
      • 5.3.2.7 Rest of Europe

    • 5.3.3 Asia-Pacific

      • 5.3.3.1 India
      • 5.3.3.2 China
      • 5.3.3.3 Japan
      • 5.3.3.4 Australia
      • 5.3.3.5 Rest of Asia-Pacific

    • 5.3.4 South America

      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America

    • 5.3.5 Middle East and Africa

      • 5.3.5.1 South Africa
      • 5.3.5.2 Saudi Arabia
      • 5.3.5.3 Rest of Middle East and Africa

• 6 COMPETITIVE LANDSCAPE

  • 6.1 Most Adopted Strategies

  • 6.2 Market Share Analysis

  • 6.3 Company Profiles

    • 6.3.1 Koninklijke DSM NV

    • 6.3.2 Zhucheng Haotian Pharm Co. Ltd

    • 6.3.3 T.J. Clark & Company

    • 6.3.4 Hebei Yuwei Biotechnology Co. Ltd

    • 6.3.5 Jingkai Biotechnology

    • 6.3.6 Shandong Runde Biotechnology Co

    • 6.3.7 Mr. Bill's Pipe & Tobacco Company

    • 6.3.8 Charles Bowman & Company

    • 6.3.9 Asiamerica Group Inc

    • 6.3.10 Ronas Chemicals Ind. Co. Ltd

• 7 MARKET OPPORTUNITIES AND FUTURE TRENDS